Cheapest Tirzepatide Providers in 2026 — Ranked & Reviewed
Tirzepatide is the most effective GLP-1 weight loss medication, but retail prices can hit $1,000+/month. We ranked every legitimate telehealth provider offering tirzepatide by their lowest published monthly cost for 2026 — so you can find a real, affordable option without falling for hidden-fee pricing.
Lowest verified price: $49/mo408 providers compared
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
408 cheapest tirzepatide providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
mainstream telehealth GLP-1 access
From /mo$99Coverage50 statesMedicationsSemaglutideTirzepatide - Best Budget
switching between compounded and brand-name GLP-1 through one provider
From /mo$99Coverage48 statesMedicationsSemaglutideTirzepatide every commitment tier priced openly, plus a low-dose microdose option
From /mo$119Flat at every doseCoverageCheck intakeMedicationsSemaglutideTirzepatidecompounded semaglutide and tirzepatide at a flat lifetime price
From /mo$119Flat at every doseCoverageCheck intakeMedicationsSemaglutideTirzepatide- Nationwide Coverage
budget-conscious shoppers
From /mo$125Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide budget-conscious shoppers
From /mo$133CoverageCheck intakeMedicationsSemaglutideTirzepatidemainstream telehealth GLP-1 access
From /mo$139Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatidebest overall value
From /mo$149Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick mainstream telehealth GLP-1 access | $99 | SemaglutideTirzepatide | 50 states | Visit → | |
Best Budget switching between compounded and brand-name GLP-1 through one provider | $99 | SemaglutideTirzepatide | 48 states | Visit → | |
 every commitment tier priced openly, plus a low-dose microdose option | $119 Flat pricing | SemaglutideTirzepatide | Check intake | Visit → | |
 compounded semaglutide and tirzepatide at a flat lifetime price | $119 Flat pricing | SemaglutideTirzepatide | Check intake | Visit → | |
Nationwide Coverage budget-conscious shoppers | $125 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 budget-conscious shoppers | $133 | SemaglutideTirzepatide | Check intake | Visit → | |
 mainstream telehealth GLP-1 access | $139 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 best overall value | $149 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
Found
Verified partnerBest for: mainstream telehealth GLP-1 access
Personalized weight care platform with a self-pay membership model plus medication costs.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
MEDVi
Verified partnerBest for: switching between compounded and brand-name GLP-1 through one provider
MEDVi is a telehealth weight-loss platform offering compounded GLP-1 injections and tablets (semaglutide) as well as brand-name Wegovy and Zepbound through licensed US pharmacies. Medical treatment is delivered by OpenLoop Health clinicians and CareGLP Affiliated P.C.s.
Score Breakdown
Pros
- ✓Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options in one platform
- ✓Oral tablet and injectable formats
- ✓Named US pharmacy partners (Triad Rx, Precision Medicine, RedRock Pharmacy, Beaker Pharmacy & Compounding)
- ✓Clinical oversight through OpenLoop Health provider network and CareGLP Affiliated P.C.s
- ✓Direct-to-home shipping with 24/7 support
Cons
- ✗Refill price for compounded GLP-1 injection ($299) steps up significantly from $179 first-month offer
- ✗Not available in Mississippi or North Dakota (telehealth regulation constraints)
- ✗Alabama and California patients can only receive injectable formats, not tablets, per state law
- ✗Kansas, Indiana, New Mexico, Oklahoma, and West Virginia require a synchronous provider visit before prescribing
- ✗No LegitScript or PCAB certification disclosed on the site
Lttl
Verified partnerBest for: every commitment tier priced openly, plus a low-dose microdose option
Lttl (pronounced 'little') is a direct-to-consumer telehealth brand offering compounded semaglutide and tirzepatide, a low-dose 'microdose' line, and longevity peptides. It publishes its full price matrix — every medication, form and commitment length — before checkout, and bills one flat rate regardless of dose. Month-to-month compounded semaglutide is $199/mo and tirzepatide $279/mo, dropping to $129 and $199 on a 12-month prepay.
Score Breakdown
Pros
- ✓Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
- ✓Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill
- ✓States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
- ✓Microdose line prices low-dose semaglutide or tirzepatide at $149/mo month-to-month for people sensitive to side effects
- ✓Oral ODT semaglutide offered for members who want to avoid injections
- ✓Cancel anytime with no contract, plus a full refund if a provider finds you medically ineligible at the initial consultation
- ✓Free shipping with cold-chain packaging and tracking; HSA and FSA funds accepted
Cons
- ✗Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
- ✗The advertised 'Plans start at $129/mo' is the 12-month prepay rate; true month-to-month is $199 semaglutide and $279 tirzepatide
- ✗No public list of states served — eligibility depends on where unnamed 'partner providers are licensed'
- ✗Site banner promises 'Prescribed and shipped within 48 hours' while the shipping policy states 2-5 business days to process plus 3-7 to deliver
- ✗Medications cannot be returned or refunded once they ship from the pharmacy
- ✗Does not bill insurance; consultation and medication are entirely out of pocket
- ✗Terms impose mandatory individual arbitration and waive class actions
- ✗Footer links to LegitScript but no certification record is published for the domain
SnagRx
Verified partnerBest for: compounded semaglutide and tirzepatide at a flat lifetime price
SnagRx is a cash-pay GLP-1 telehealth service from Modern Metabolic Medicine, Inc. offering compounded semaglutide and compounded tirzepatide shipped to your door in 1-2 days. Pricing is flat for life at the same price every dose, with a launch discount taking semaglutide to $99/mo and tirzepatide to $149/mo. No insurance, no membership; telehealth visit and shipping included.
Score Breakdown
Pros
- ✓Compounded semaglutide ($99/mo) and tirzepatide ($149/mo) month-to-month, flat-priced at every dose; longer commitments cut it to $69/$119
- ✓Names four partner pharmacies in Terms (RedRock, Health Warehouse, Precision Compounding, Triad Rx)
- ✓Available in all 50 states plus Washington D.C. per Terms
- ✓Telemed visit, prescription and free 1-2 day shipping included; no insurance or membership
- ✓Cancel anytime; full refund if disqualified by the medical provider
Cons
- ✗The struck-through $299/$399 is a permanent anchor, not a rate anyone pays - still struck through beside a countdown reading 00:00:00:00
- ✗No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only
- ✗Refunds only available before medication is ordered; all sales otherwise final
- ✗Binding JAMS arbitration under Delaware law; class-action waiver
Trimi Health
Verified partnerBest for: budget-conscious shoppers
Telehealth provider offering some of the lowest compounded GLP-1 pricing available.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
How to find the cheapest legitimate tirzepatide
Compounded tirzepatide can be far cheaper than brand-name Zepbound — but the cheapest listing isn't automatically the best. Here's how to compare honestly.
What to look for
- Compare the real monthly total. Sort by the ongoing per-month price including membership, not the intro offer. A '$99 first month' can become $300+ ongoing.
- Longer plans win on price, lose on flexibility. 12-month plans post the lowest per-month numbers but require commitment. Balance the savings against not knowing yet how you'll tolerate the medication.
- Never trade safety for price. A rock-bottom price with no named pharmacy or LegitScript listing isn't a deal — it's an unknown. Keep the trust score in view.
Red flags to avoid
- No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
- Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
- Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
- Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.